FindMyRecallSubscribe
Class III: unlikely to cause harmCompleted

Baxter Healthcare Bendamustine HCl Injection Recall

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only,…

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class III
Reported by FDA
Aug 30, 2023
Recall ID
D-1103-2023
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Bendamustine HCl Injection starting Aug 14, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1103-2023 on Aug 30, 2023. Reason: Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial. Status: Completed.

Why it was recalled

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Product description

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Lot numbers, UPCs & expiration codes

Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025

Where it was sold

Nationwide in the U.S.A.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1103-2023
Classification
Class III
Status
Completed
Recall initiated
Aug 14, 2023
FDA report date
Aug 30, 2023
Quantity
13,502 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-1103-2023, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Completed
Country
United States
Event ID
92887
Address
1 Baxter Pkwy
Code information
Lots: 3A004A, 3A004B, Exp 12/31/2024; 3B005A, Exp 1/31/2025
Postal code
60015-4625
Report date
Aug 30, 2023
Product type
Drugs
Recall number
D-1103-2023
Classification
Class III
Recalling firm
Baxter Healthcare Corporation
Product quantity
13,502 vials
Reason for recall
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Distribution pattern
Nationwide in the U.S.A.
Recall initiation date
Aug 14, 2023
Initial firm notification
Letter
Center classification date
Aug 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1103-2023, published Aug 30, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls